Inventor · disambiguated record
Stephen Dudley Holmes
Also filed as: HOLMES STEPHEN D · HOLMES STEPHEN DUDLEY
17 granted patents·8 pending applications·576 citations·filing 1995–2010
96Inventor score
Files withSMITHKLINE BEECHAM CORP16SMITHKLINE BEECHAM PLC5GLAXOSMITHKLINE LLC2SMITHKLINE BEECHAM CORP AND SM1SMITHKLINE BEECHUM CORP1
Top patents by PatentIndex Score
25 records- 0195US7982005B2Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disordersGLAXOSMITHKLINE LLC·Filed 2010·Granted Jul 19, 2011·44 cites·11 claims
- 0293US6998124B1Erythropoietin receptor antibodiesSMITHKLINE BEECHAM CORP·Filed 2000·Granted Feb 14, 2006·39 cites·16 claims
- 0389US7399837B2Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disordersSMITHKLINE BEECHAM CORP·Filed 2005·Granted Jul 15, 2008·13 cites·10 claims
- 0489US6706487B1Monoclonal antibody and the method of using the antibodySMITHKLINE BEECHAM CORP·Filed 2000·Granted Mar 16, 2004·39 cites·8 claims
- 0586US6376653B1Tie2 antagonist antibodiesSMITHKLINE BEECHAM PLC·Filed 1999·Granted Apr 23, 2002·68 cites·6 claims
- 0685US6129913ARecombinant IL-5 antagonists useful in treatment of IL-5 mediated disordersSMITHKLINE BEECHAM CORP·Filed 1995·Granted Oct 10, 2000·68 cites·8 claims
- 0784US6365154B1Tie2 agonist antibodiesSMITHKLINE BEECHAM CORP·Filed 1999·Granted Apr 2, 2002·46 cites·27 claims
- 0883US6946130B2Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disordersSMITHKLINE BEECHAM PLC·Filed 2003·Granted Sep 20, 2005·13 cites·9 claims
- 0983US5928904ADNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disordersSMITHKLINE BEECHAM CORP·Filed 1995·Granted Jul 27, 1999·59 cites·33 claims
- 1081US5683892ADNA encoding recombinant IL-5 antagonists useful in treatment of IL-5 mediated disordersSMITHKLINE BEECHAM CORP·Filed 1995·Granted Nov 4, 1997·35 cites·15 claims
- 1178US5914110ARecombinant IL4 antibodies useful in treatment of IL4 mediated disordersSMITHKLINE BEECHAM CORP·Filed 1995·Granted Jun 22, 1999·31 cites·39 claims
- 1278US5726061AMethod of diagnosing and monitoring colorectal cancerSMITHKLINE BEECHUM CORP·Filed 1996·Granted Mar 10, 1998·58 cites·4 claims
- 1377US5851525ARecombinant IL-5 antagonists useful in treatment of IL-5 mediated disordersSMITHKLINE BEECHAM CORP·Filed 1997·Granted Dec 22, 1998·29 cites·24 claims
- 1477US5693323ARecombinant IL-5 antagonists useful in treatment of IL-5 mediated disordersSMITHKLINE BEECHAM CORP·Filed 1995·Granted Dec 2, 1997·30 cites·22 claims
- 1562US2005002959A1Recombinant IL4 antibodies useful in treatment of IL4 mediated disordersSMITHKLINE BEECHAM PLC·Filed 2003·Application pending·0 cites
- 1661US2009017020A1Recombinant il-5 antagonists useful in treatment of il-5 mediated disordersSMITHKLINE BEECHAM PLC·Filed 2008·Application pending·0 cites
- 1759US7807793B2Recombinant IL4 antibodies useful in treatment of IL4 mediated disordersGLAXOSMITHKLINE LLC·Filed 2006·Granted Oct 5, 2010·0 cites·6 claims
- 1855US2002193575A1Recombinant IL4 antibodies useful in treatment of IL4 mediated disordersSMITHKLINE BEECHAM PLC·Filed 2001·Application pending·0 cites
- 1953US2003059429A1Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disordersSMITHKLINE BEECHAM CORP·Filed 2002·Application pending·0 cites
- 2049US2004141964A1Recombinant IL-18 antagonists useful in treatment of IL-18 mediated disordersSMITHKLINE BEECHAM CORP AND SM·Filed 2004·Application pending·0 cites
- 2143US2005244409A1Erythropoietin receptor antibodiesSMITHKLINE BEECHAM CORP·Filed 2005·Application pending·0 cites
- 2242US6358704B1M proteinSMITHKLINE BEECHAM CORP·Filed 1999·Granted Mar 19, 2002·3 cites·7 claims
- 2340US2002127227A1RHAMM antagonist antibodiesSMITHKLINE BEECHAM CORP·Filed 2002·Application pending·0 cites
- 2438US2002102258A1Human tumor necrosis factor receptor-like 2 (TR2) antibodiesSMITHKLINE BEECHAM CORP·Filed 2001·Application pending·0 cites
- 2536US5882896AM proteinSMITHKLINE BEECHAM CORP·Filed 1997·Granted Mar 16, 1999·1 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Stephen Dudley Holmes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →